Publication | Closed Access

Serum Isoform [−2]proPSA Derivatives Significantly Improve Prediction of Prostate Cancer at Initial Biopsy in a Total PSA Range of 2–10 ng/ml: A Multicentric European Study

Biomarker (Medicine)Prognostic BiomarkersUrologyOncologyEngineeringGenitourinary CancerMedicineBiomedical AnalysisImprove PredictionProstatic DiseaseInitial BiopsyMolecular DiagnosticsRadiation OncologyCancer ResearchMolecular Oncology